Atsuo Tamura

Dr. Atsuo Tamura


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FSFumi Shima
Fumi Shima
YYYoko Yoshikawa
Yoko Yoshikawa
MYMin Ye
Min Ye
MAMitsugu Araki
Mitsugu Araki
SMShigeyuki Matsumoto
Shigeyuki Matsumoto
TKTohru Kataoka
Tohru Kataoka
Mutational activation of the Ras oncogene products (H-Ras, K-Ras, and N-Ras) is frequently observed in human cancers, making them promising anticancer drug targets. Nonetheless, no effective strategy has been available for the development of Ras inhibitors, partly owing to the absence of well-defined surface pockets suitable for drug binding. Only recently, such pockets have been found in the crystal structures of a unique conformation of Ras⋅GTP. Here we report the successful development of small-molecule Ras inhibitors by an in silico screen targeting a pocket found in the crystal structure of M-Ras⋅GTP carrying an H-Ras–type substitution P40D. The selected compound Kobe0065 and its analog Kobe2602 exhibit inhibitory activity toward H-Ras⋅GTP-c-Raf-1 binding both in vivo and in vitro. They effectively inhibit both anchorage-dependent and -independent growth and induce apoptosis of H- ras G12V –transformed NIH 3T3 cells, which is accompanied by down-regulation of downstream molecules such as MEK/ERK, Akt, and RalA as well as an upstream molecule, Son of sevenless. Moreover, they exhibit antitumor activity on a xenograft of human colon carcinoma SW480 cells carrying the K-ras G12V gene by oral administration. The NMR structure of a complex of the compound with H-Ras⋅GTP T35S , exclusively adopting the unique conformation, confirms its insertion into one of the surface pockets and provides a molecular basis for binding inhibition toward multiple Ras⋅GTP-interacting molecules. This study proves the effectiveness of our strategy for structure-based drug design to target Ras⋅GTP, and the resulting Kobe0065-family compounds may serve as a scaffold for the development of Ras inhibitors with higher potency and specificity.

1 July 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FSFumi Shima
Fumi Shima
YIYuichi Ijiri
Yuichi Ijiri
SMShin Muraoka
Shin Muraoka
JLJingling Liao
Jingling Liao
MYMin Ye
Min Ye
TKTohru Kataoka
Tohru Kataoka
Ras family small GTPases assume two interconverting conformations, “inactive” state 1 and “active” state 2, in their GTP-bound forms. Here, to clarify the mechanism of state transition, we have carried out x-ray crystal structure analyses of a series of mutant H-Ras and M-Ras in complex with guanosine 5′-(β,γ-imido)triphosphate (GppNHp), representing various intermediate states of the transition. Crystallization of H-RasT35S-GppNHp enables us to solve the first complete tertiary structure of H-Ras state 1 possessing two surface pockets unseen in the state 2 or H-Ras-GDP structure. Moreover, determination of the two distinct crystal structures of H-RasT35S-GppNHp, showing prominent polysterism in the switch I and switch II regions, reveals a pivotal role of the guanine nucleotide-mediated interaction between the two switch regions and its rearrangement by a nucleotide positional change in the state 2 to state 1 transition. Furthermore, the 31P NMR spectra and crystal structures of the GppNHp-bound forms of M-Ras mutants, carrying various H-Ras-type amino acid substitutions, also reveal the existence of a surface pocket in state 1 and support a similar mechanism based on the nucleotide-mediated interaction and its rearrangement in the state 1 to state 2 transition. Intriguingly, the conformational changes accompanying the state transition mimic those that occurred upon GDP/GTP exchange, indicating a common mechanistic basis inherent in the high flexibility of the switch regions. Collectively, these results clarify the structural features distinguishing the two states and provide new insights into the molecular basis for the state transition of Ras protein.

1 November 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MAMitsugu Araki
Mitsugu Araki
FSFumi Shima
Fumi Shima
YYYoko Yoshikawa
Yoko Yoshikawa
SMShin Muraoka
Shin Muraoka
YIYuichi Ijiri
Yuichi Ijiri
ATAtsuo Tamura
Atsuo Tamura
Ras small GTPases undergo dynamic equilibrium of two interconverting conformations, state 1 and state 2, in the GTP-bound forms, where state 2 is recognized by effectors, whereas physiological functions of state 1 have been unknown. Limited information, such as static crystal structures and 31P NMR spectra, was available for the study of the conformational dynamics. Here we determine the solution structure and dynamics of state 1 by multidimensional heteronuclear NMR analysis of an H-RasT35S mutant in complex with guanosine 5′-(β, γ-imido)triphosphate (GppNHp). The state 1 structure shows that the switch I loop fluctuates extensively compared with that in state 2 or H-Ras-GDP. Also, backbone 1H,15N signals for state 2 are identified, and their dynamics are studied by utilizing a complex with c-Raf-1. Furthermore, the signals for almost all the residues of H-Ras·GppNHp are identified by measurement at low temperature, and the signals for multiple residues are found split into two peaks corresponding to the signals for state 1 and state 2. Intriguingly, these residues are located not only in the switch regions and their neighbors but also in the rigidly structured regions, suggesting that global structural rearrangements occur during the state interconversion. The backbone dynamics of each state show that the switch loops in state 1 are dynamically mobile on the picosecond to nanosecond time scale, and these mobilities are significantly reduced in state 2. These results suggest that multiconformations existing in state 1 are mostly deselected upon the transition toward state 2 induced by the effector binding.

1 September 2005 in Biophysical Journal
Verified
Journal Article
Closed access
KYKohji Yamamoto
Kohji Yamamoto
KTKeisuke Tominaga
Keisuke Tominaga
HSHiroaki Sasakawa
Hiroaki Sasakawa
ATAtsuo Tamura
Atsuo Tamura
HMHidetoshi Murakami
Hidetoshi Murakami
NSNobuhiko Sarukura
Nobuhiko Sarukura

1 May 2003 in Structure
Verified
Journal Article
Closed access
WJWenzhen Jin
Wenzhen Jin
OKOhki Kambara
Ohki Kambara
HSHiroaki Sasakawa
Hiroaki Sasakawa
ATAtsuo Tamura
Atsuo Tamura
STShoji Takada
Shoji Takada

1 February 2009 in Journal of Molecular Biology
Verified
Journal Article
Closed access
DHDaizo Hamada
Daizo Hamada
TTToshiki Tanaka
Toshiki Tanaka
Gian Gaetano TartagliaGian Gaetano Tartaglia
Gian Gaetano Tartaglia
APAmol Pawar
Amol Pawar
Michele VendruscoloMichele Vendruscolo
Michele Vendruscolo
CDChristopher M. Dobson
Christopher M. Dobson